From August 1, Changchun, with the city's public medical institutions as the main body of volume-based procurement, officially implemented the results of the selection of the centralized procurement of the third batch of drugs in "Eight Provinces and Two Regions" (Heilongjiang, Shanxi, Qinghai, Liaoning, Jilin, Hainan, Sichuan, Guizhou, Tibet Autonomous Region, Inner Mongolia Autonomous Region) and the results of the selection of orthopedic trauma medical consumables in the "3+N" Alliance of Beijing, Tianjin and Hebei, and renewed the contract for the centralized procurement of drugs of the second and fourth batches organized by the state to fully promote the implementation of centralized procurement and the use of such products by the state and inter-provincial alliances.

　　As a beneficial supplement to the national centralized procurement, the volume-based procurement of inter-provincial alliances has brought more concessions to patients in Changchun. A total of 17 product categories and 23 product specifications were selected by the "Eight Provinces and Two Regions" Alliance, with an average decrease of 54.76%. It is estimated that at least RMB 5.29 million will be saved for the people of Changchun every year. In terms of therapeutic category, this centralized procurement is mainly composed of the procurement of systemic anti-infectives, digestive and metabolic drugs, and cardiovascular drugs. Among them, five systemic anti-infectives include: cefotaxime sodium, ceftizoxime sodium injection, ornidazole and sodium chloride injection, clindamycin injection, cefoperazone injection, and three digestive and metabolic drugs are: calcitriol soft capsule, compound glycyrrhizin injection, nicotinamide injection, which are all "major varieties" with high sales and expenses commonly used in clinic.

　　A total of 20,858 products from 89 enterprises were selected in the volume-based joint procurement made by the "3+N" Alliance of Beijing, Tianjin and Hebei for orthopedic trauma medical consumables, with an average price reduction of 83.48%. The great reduction in price of orthopedic trauma medical consumables greatly reduces the burden of patients in medical treatment and eliminates their worries that "dare not treat" in the process of seeking medical treatment.

　　In the renewal of centralized procurement of drugs of the second and fourth batches organized by the state, a total of 73 product specifications continue to be purchased this time. These include drugs for major chronic diseases such as hypertension and diabetes, as well as expensive antineoplastics and drugs for rare diseases, which can be bought in public hospitals. The medical insurance departments of Changchun will implement the national centralized procurement and contract renewal policy from the aspects of system guarantee, policy advocacy, department coordination, daily monitoring, etc., to ensure the smooth implementation of the work benefiting the people and high-quality and low-cost drugs provided for the citizens in a timely manner.